Molecular chaperones, many of which are heat-shock proteins (HSPs), are an important class of molecules with various functions. Pathological conditions in which chaperones become etiological and/or pathogenic factors are called chaperonopathies, and are classified into by defect, by excess, and by "mistake". In the latter case, the chaperone is structurally and functionally normal but paqrtecipates in pathwais that favor diseases, aòlthough in some cases the chaperone may have post-translational modifications that may lead it to change its location and function and, thus, to become pathogenic. For example, HSP-chaperones are involved in acrcinogenesis in various ways, so that some forms of cancer may be considered "chaperonopathies by mistake". This concept suggests new strategies for anticancer therapy (chaperonotherapy), in which the primary targets or therapeutic agents are choaperones. Chaperonotherapy consists of the utilization of HSP-chaperones for treating chaperonopathies, including cancer. Negative chaperonotherapy is aimed at eliminating or blocking the action of chaperones that favour carcinogenesis or other diseases, whereas positive chaperonotherapy uses chaperones, genes or proteins, to gight against dioseases, such cancer, by stimulating the immune system or the cellular defences against stress.

RAPPA, F., FARINA, F., ZUMMO, G., DAVID, S., CAMPANELLA, C., CARINI, F., et al. (2012). HSP-MOLECULAR CHAPERONES IN CANCER BIOGENESIS AND TUMOR THERAPY: AN OVERVIEW. ANTICANCER RESEARCH, 32, 5139-5150.

HSP-MOLECULAR CHAPERONES IN CANCER BIOGENESIS AND TUMOR THERAPY: AN OVERVIEW

RAPPA, Francesca;FARINA, Felicia;ZUMMO, Giovanni;DAVID, Sabrina;CAMPANELLA, Claudia;CARINI, Francesco;TOMASELLO, Giovanni;CAPPELLO, Francesco;
2012-01-01

Abstract

Molecular chaperones, many of which are heat-shock proteins (HSPs), are an important class of molecules with various functions. Pathological conditions in which chaperones become etiological and/or pathogenic factors are called chaperonopathies, and are classified into by defect, by excess, and by "mistake". In the latter case, the chaperone is structurally and functionally normal but paqrtecipates in pathwais that favor diseases, aòlthough in some cases the chaperone may have post-translational modifications that may lead it to change its location and function and, thus, to become pathogenic. For example, HSP-chaperones are involved in acrcinogenesis in various ways, so that some forms of cancer may be considered "chaperonopathies by mistake". This concept suggests new strategies for anticancer therapy (chaperonotherapy), in which the primary targets or therapeutic agents are choaperones. Chaperonotherapy consists of the utilization of HSP-chaperones for treating chaperonopathies, including cancer. Negative chaperonotherapy is aimed at eliminating or blocking the action of chaperones that favour carcinogenesis or other diseases, whereas positive chaperonotherapy uses chaperones, genes or proteins, to gight against dioseases, such cancer, by stimulating the immune system or the cellular defences against stress.
2012
Settore BIO/16 - Anatomia Umana
Settore MED/18 - Chirurgia Generale
Settore MED/09 - Medicina Interna
RAPPA, F., FARINA, F., ZUMMO, G., DAVID, S., CAMPANELLA, C., CARINI, F., et al. (2012). HSP-MOLECULAR CHAPERONES IN CANCER BIOGENESIS AND TUMOR THERAPY: AN OVERVIEW. ANTICANCER RESEARCH, 32, 5139-5150.
File in questo prodotto:
File Dimensione Formato  
HSP MOLECULAR CHAPERONES IN CANCER BIOGENESIS AND TUMOR. ANTICANCER RESEARCH. 2012.pdf

Solo gestori archvio

Dimensione 260.55 kB
Formato Adobe PDF
260.55 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/68603
Citazioni
  • ???jsp.display-item.citation.pmc??? 52
  • Scopus 111
  • ???jsp.display-item.citation.isi??? 111
social impact